Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 73 EP11 | DOI: 10.1530/endoabs.73.EP11

1The Military Hospital of Tunis, Urology, Tunis, Tunisia; 2The Military Hospital of Tunis, Endocrinology, Tunis, Tunisia


Background

Adrenocortical carcinoma is a rare endocrine malignancy, with an unfavorable prognosis. Radical adrenalectomy is the gold standard for localized disease.

Case presentation

We report a case of a 47-year-old male with left abdominal pain and sensation of discomfort. Our patient didn’t present classical tumor symptoms, such as cachexia or night sweats. Computed tomography revealed a left heterogeneous retroperitoneal enhancing adrenal mass measuring 17 cm, with high density (30 Hounsfield units), smooth margins, and a wash-out <60%. Hormonal evaluation was negative, with normal ACTH and cortisol level. Suppression test was negative. Measurement of plasma renin activity and serum aldosterone levels showed no abnormalities. Plasmatic metanephrine and normetanephrine was also normal, excluding a pheochromocytoma. Open left adrenalectomy was performed by sub-costal approach. Pathology confirmed the diagnosis of adrenocortical carcinoma with positive microscopic surgical margins. Metastatic workup was negative. This case was discussed at a tumor board meeting. Adjuvant treatment by mitotane was not recommended. The patient has undergone a regular follow-up and has been disease-free for 6 months.

Conclusion

Adrenocortical carcinoma is a diagnosis challenge. Surgery remains the main treatment. A multidisciplinary management should be offered in those cases.

Volume 73

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.